373728005: Montelukast (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Leukotriene receptor antagonist\Montelukast (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Respiratory system agent (substance)\Leukotriene receptor antagonist\Montelukast (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Montelukast (substance)	Is a	Leukotriene receptor antagonist	true	Inferred relationship	Some
Montelukast (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Leukotriene receptor antagonist (disposition)	true	Inferred relationship	Some
Montelukast (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Montelukast sodium (substance)	Is a	False	Montelukast (substance)	Inferred relationship	Some
Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 each conventional release chewable tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Montelukast (substance)	Inferred relationship	Some
Product containing montelukast (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Montelukast (substance)	Inferred relationship	Some	1
Product containing precisely montelukast (as montelukast sodium) 5 milligram/1 each conventional release chewable tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Montelukast (substance)	Inferred relationship	Some
Montelukast sodium 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Montelukast (substance)	Inferred relationship	Some
Montelukast sodium 4 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Montelukast (substance)	Inferred relationship	Some
Montelukast sodium 4mg oral granules	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Montelukast (substance)	Inferred relationship	Some
Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Montelukast (substance)	Inferred relationship	Some
Montelukast (as montelukast sodium) 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Montelukast (substance)	Inferred relationship	Some	1
Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 each conventional release chewable tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Montelukast (substance)	Inferred relationship	Some	1
Product containing precisely montelukast (as montelukast sodium) 5 milligram/1 each conventional release chewable tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Montelukast (substance)	Inferred relationship	Some	1
Montelukast-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Montelukast (substance)	Inferred relationship	Some	1
Montelukast sodium (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Montelukast (substance)	Inferred relationship	Some
Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Montelukast (substance)	Inferred relationship	Some	1
Montelukast only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Montelukast (substance)	Inferred relationship	Some	1
Product containing only montelukast in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Montelukast (substance)	Inferred relationship	Some	1
Product containing bambuterol and montelukast (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Montelukast (substance)	Inferred relationship	Some	1
Bambuterol and montelukast only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Montelukast (substance)	Inferred relationship	Some	1
Bambuterol- and montelukast-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Montelukast (substance)	Inferred relationship	Some	1
Bambuterol and montelukast only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Montelukast (substance)	Inferred relationship	Some	1
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Montelukast (substance)	Inferred relationship	Some	1
Levocetirizine- and montelukast-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Montelukast (substance)	Inferred relationship	Some	1
Product containing only levocetirizine and montelukast in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Montelukast (substance)	Inferred relationship	Some	1
Levocetirizine dihydrochloride 5 mg and montelukast (as montelukast sodium) 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Montelukast (substance)	Inferred relationship	Some	1
Product containing levocetirizine and montelukast (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Montelukast (substance)	Inferred relationship	Some	1
Levocetirizine and montelukast only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Montelukast (substance)	Inferred relationship	Some	1
Product containing precisely levocetirizine dihydrochloride 2.5 milligram and montelukast (as montelukast sodium) 4 milligram/1 each tablet for conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Montelukast (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1199028010	Montelukast (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1212183012	Montelukast	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
53971000195110	montelukast	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
826251000172114	montélukast	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
68101000195117	Montelukast	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module